Latest News about Downgrades
Recent news which mentions Downgrades
Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts
November 25, 2024
From Benzinga
Nio Analyst Sees Tougher Path To Profitability, Downgrades EV Maker To Sell: What You Need To Know
November 25, 2024
From Benzinga
This Nio Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
November 25, 2024
From Benzinga
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
November 22, 2024
From Benzinga
This Ulta Beauty Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
November 21, 2024
From Benzinga
From Benzinga
Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns
November 21, 2024
From Benzinga
From Benzinga
This Kraft Heinz Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
November 19, 2024
From Benzinga
Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
November 18, 2024
From Benzinga
Goldman Sachs Turns Bearish On Redfin: 'Affordability Could Weigh On A Housing Recovery'
November 18, 2024
From Benzinga
From Benzinga
Trump's Win, Economic Challenges Lead to Tougher Outlook for Renewable Energy Stocks: Morgan Stanley
November 15, 2024
From Benzinga
JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options
November 15, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.